Targeting NSCLC patients with EGFR Ex19Del or L858R mutations, 3rd generation irreversible EGFR-TKI, anti-CNS metastasis activity, oral,
Sale!
Lucius
Replica: Osimertinib for EGFRm NSCLC with Ex19Del or L858R
Original price was: $738.00.$579.00Current price is: $579.00.
Targeting NSCLC patients with EGFR Ex19Del or L858R mutations, 3rd generation irreversible EGFR-TKI, anti-CNS metastasis activity, oral,
Reviews
There are no reviews yet.